FTC sues important pharmacy reward professionals more than insulin prices The agency brought action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of lifestyle-saving insulin prescription drugs. Insurers will carry on vertically integrating to help keep much more revenue https://edwinbdccc.bloguerosa.com/29915784/not-known-facts-about-healthcare-news